albuterol has been researched along with Hypercapnia in 13 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
Hypercapnia: A clinical manifestation of abnormal increase in the amount of carbon dioxide in arterial blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| "5 mg) albuterol (salbutamol) over 1 h in 47 patients admitted to hospital with severe acute asthma defined as a peak expiratory flow (PEF) below 150 L/min and hypercapnia (Pa(CO2) > or = 40 mm Hg)." | 9.07 | Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study. ( Brochard, L; Duroux, P; Henry-Amar, M; Mal, H; Renon, D; Salmeron, S; Simonneau, G; Tenaillon, A, 1994) |
| "Under stable conditions most subjects with severe COPD and hypercapnia will have a fall in P(a)CO(2) and P(a)O(2) following 10 mg rac-albuterol, suggesting that they maintain capacity to respond to any increase in VCO(2) and prevent a rise in P(a)CO(2)." | 5.12 | Effects of rac-albuterol on arterial blood gases in patients with stable hypercapnic chronic obstructive pulmonary disease. ( Cooper, S; Harrison, TW; Mortimer, K; Oborne, J; Sovani, MP; Tattersfield, AE; Whale, CI, 2006) |
| "5 mg) albuterol (salbutamol) over 1 h in 47 patients admitted to hospital with severe acute asthma defined as a peak expiratory flow (PEF) below 150 L/min and hypercapnia (Pa(CO2) > or = 40 mm Hg)." | 5.07 | Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study. ( Brochard, L; Duroux, P; Henry-Amar, M; Mal, H; Renon, D; Salmeron, S; Simonneau, G; Tenaillon, A, 1994) |
| "The goal of management of patients with respiratory failure is to restore them to a state of quiet breathing, without complication." | 2.41 | Management of respiratory failure in patients with asthma. ( Corbridge, T; Gluckman, TJ, 2000) |
| " Therefore, we infused salbutamol at a higher dosage (23." | 1.35 | Effect of salbutamol on respiratory muscle function and ventilation in awake canines. ( Easton, PA; Holroyde, MC; Johnson, MW; Katagiri, M; Kusuhara, N; Rothwell, BC, 2008) |
| " Given via the trachea, salbutamol bioavailability was decreased by hypoxia." | 1.29 | Influence of hypoxia and hypercapnia on the kinetics and hypokaliaemic effect of salbutamol in the rabbit. ( Du Souich, P; Ong, H; Perreault, S; Saunier, C, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 2 (15.38) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, J | 1 |
| Cui, Z | 1 |
| Liu, S | 1 |
| Gao, X | 1 |
| Gao, P | 1 |
| Shi, Y | 1 |
| Guo, S | 1 |
| Li, P | 1 |
| Richie, RC | 1 |
| Angulo, M | 1 |
| Taranto, E | 1 |
| Soto, JP | 1 |
| Malacrida, L | 1 |
| Nin, N | 1 |
| Hurtado, FJ | 1 |
| Píriz, H | 1 |
| Gunkel, CI | 1 |
| Valverde, A | 1 |
| Robertson, SA | 1 |
| Thompson, MS | 1 |
| Keoughan, CG | 1 |
| Ferrell, EA | 1 |
| Mazzeo, AT | 1 |
| Spada, A | 1 |
| Praticò, C | 1 |
| Lucanto, T | 1 |
| Santamaria, LB | 1 |
| Xu, X | 1 |
| Zhou, J | 1 |
| Yang, Q | 1 |
| Fang, L | 1 |
| Xie, Q | 1 |
| Shen, Y | 1 |
| Udy, A | 1 |
| Whale, CI | 1 |
| Sovani, MP | 1 |
| Mortimer, K | 1 |
| Oborne, J | 1 |
| Cooper, S | 1 |
| Harrison, TW | 1 |
| Tattersfield, AE | 1 |
| Easton, PA | 1 |
| Katagiri, M | 1 |
| Johnson, MW | 1 |
| Rothwell, BC | 1 |
| Holroyde, MC | 1 |
| Kusuhara, N | 1 |
| Perreault, S | 1 |
| Saunier, C | 1 |
| Ong, H | 1 |
| Du Souich, P | 1 |
| Salmeron, S | 1 |
| Brochard, L | 1 |
| Mal, H | 1 |
| Tenaillon, A | 1 |
| Henry-Amar, M | 1 |
| Renon, D | 1 |
| Duroux, P | 1 |
| Simonneau, G | 1 |
| Gluckman, TJ | 1 |
| Corbridge, T | 1 |
| Lim, TK | 1 |
| Tan, WC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Pulmonary Gas Exchange Response to Indacaterol in Stable Symptomatic Chronic Obstructive Pulmonary Disease Patients[NCT02547558] | Phase 4 | 20 participants (Anticipated) | Interventional | 2015-10-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for albuterol and Hypercapnia
| Article | Year |
|---|---|
Management of respiratory failure in patients with asthma.
Topics: Administration, Inhalation; Albuterol; Asthma; Bronchodilator Agents; Calcium Channel Blockers; Gluc | 2000 |
2 trials available for albuterol and Hypercapnia
| Article | Year |
|---|---|
Effects of rac-albuterol on arterial blood gases in patients with stable hypercapnic chronic obstructive pulmonary disease.
Topics: Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Albuterol; Area Under Curve; Bronchodilato | 2006 |
Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study.
Topics: Acute Disease; Administration, Inhalation; Adolescent; Adult; Aged; Albuterol; Analysis of Variance; | 1994 |
10 other studies available for albuterol and Hypercapnia
| Article | Year |
|---|---|
Early use of noninvasive techniques for clearing respiratory secretions during noninvasive positive-pressure ventilation in patients with acute exacerbation of chronic obstructive pulmonary disease and hypercapnic encephalopathy: A prospective cohort stud
Topics: Aged; Albuterol; Ambroxol; Brain Diseases; Equipment Design; Feasibility Studies; Female; Humans; Hy | 2017 |
Assessing mortality risk in COPD.
Topics: Actuarial Analysis; Albuterol; Androstadienes; Body Mass Index; Bronchial Hyperreactivity; Bronchodi | 2008 |
[Salbutamol improves diaphragmatic contractility in chronic airway obstruction].
Topics: Adrenergic beta-Agonists; Airway Obstruction; Albuterol; Alkalosis; Animals; Chronic Disease; Diaphr | 2009 |
Treatment for a severe reaction to intravenous administration of diatrizoate in an anesthetized horse.
Topics: Aerosols; Albuterol; Anesthesia; Animals; Bronchoconstriction; Bronchodilator Agents; Contrast Media | 2004 |
Hypercapnia: what is the limit in paediatric patients? A case of near-fatal asthma successfully treated by multipharmacological approach.
Topics: Acidosis, Respiratory; Albuterol; Asthma; Bronchodilator Agents; Child; Drug Therapy, Combination; G | 2004 |
An in vitro rat diaphragmatic fatigue model induced by combined hypoxic and hypercapnic acidosis and the effect of salmeterol.
Topics: Acidosis; Adrenergic beta-Agonists; Albuterol; Aminophylline; Animals; Bronchodilator Agents; Diaphr | 2006 |
A 10-year-old child with status asthmaticus, hypercapnia and a unilateral dilated pupil.
Topics: Albuterol; Bronchodilator Agents; Child; Humans; Hypercapnia; Ipratropium; Male; Mydriasis; Nebulize | 2005 |
Effect of salbutamol on respiratory muscle function and ventilation in awake canines.
Topics: Albuterol; Animals; Bronchodilator Agents; Dogs; Dose-Response Relationship, Drug; Electromyography; | 2008 |
Influence of hypoxia and hypercapnia on the kinetics and hypokaliaemic effect of salbutamol in the rabbit.
Topics: Administration, Oral; Albuterol; Animals; Half-Life; Hypercapnia; Hypoxia; Infusions, Intravenous; K | 1995 |
Acute carbon dioxide narcosis during inhalational therapy with oxygen powered nebulizers in patients with chronic airflow limitation.
Topics: Aerosols; Aged; Albuterol; Female; Humans; Hypercapnia; Lung Diseases, Obstructive; Male; Middle Age | 1985 |